Apelin, a peptide initially isolated from bovine stomach extract, is an endogenous ligand for the Apelin Receptor (APLNR). Subsequently, a second peptide, ELABELA, that can bind to the receptor has been identified. The Apelin receptor and its endogenous ligands are widely distributed in mammalian organs. A growing body of evidence suggests that this system participates in various signaling cascades that can regulate cell proliferation, blood pressure, fluid homeostasis, feeding behavior, and pituitary hormone release. Additional research has been done to elucidate the system’s potential role in neurogenesis, the pathophysiology of Glioblastoma multiforme, and the protective effects of apelin peptides on some neurological and psychiatric disorders-ischemic stroke, epilepsy, Parkinson’s, and Alzheimer’s disease. This review discusses the current knowledge on the apelinergic system’s involvement in brain physiology in health and disease.
CITATION STYLE
Ivanov, M. N., Stoyanov, D. S., Pavlov, S. P., & Tonchev, Anton. B. (2022). Distribution, Function, and Expression of the Apelinergic System in the Healthy and Diseased Mammalian Brain. Genes, 13(11), 2172. https://doi.org/10.3390/genes13112172
Mendeley helps you to discover research relevant for your work.